BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20460897)

  • 1. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for primary sclerosing cholangitis.
    Vierling JM
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):591-610. PubMed ID: 11492970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
    Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
    J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine models of autoimmune cholangitis.
    Ueno Y; Ambrosini YM; Moritoki Y; Ridgway WM; Gershwin ME
    Curr Opin Gastroenterol; 2010 May; 26(3):274-9. PubMed ID: 20224397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
    Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
    Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
    Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
    J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
    Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
    Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β2 silencing to target biliary-derived liver diseases.
    Dropmann A; Dooley S; Dewidar B; Hammad S; Dediulia T; Werle J; Hartwig V; Ghafoory S; Woelfl S; Korhonen H; Janicot M; Wosikowski K; Itzel T; Teufel A; Schuppan D; Stojanovic A; Cerwenka A; Nittka S; Piiper A; Gaiser T; Beraza N; Milkiewicz M; Milkiewicz P; Brain JG; Jones DEJ; Weiss TS; Zanger UM; Ebert M; Meindl-Beinker NM
    Gut; 2020 Sep; 69(9):1677-1690. PubMed ID: 31992593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will we ever model PSC? - "it's hard to be a PSC model!".
    Pollheimer MJ; Trauner M; Fickert P
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35(12):792-804. PubMed ID: 21703962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.
    Sato K; Glaser S; Kennedy L; Liangpunsakul S; Meng F; Francis H; Alpini G
    Expert Opin Ther Targets; 2019 Jun; 23(6):461-472. PubMed ID: 30990740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of primary sclerosing cholangitis.
    Pollheimer MJ; Halilbasic E; Fickert P; Trauner M
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):727-39. PubMed ID: 22117638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
    Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
    J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.